Midterm outcomes of percutaneous transluminal septal myocardial ablation in patients with hypertroph

• 作 者: CHEN Shao-liang YE Fei XU Zu-l
• 机 构: Cardiological Division, Nanjing First Hospital of Nanjing Medical University, Nanjing 210006, China“
• 出 处: 中华医学杂志（英文版）
• 发表日期: 2006年13期
• 关键词: hypertrophic obstructive cardiomyopathy percutaneous transluminal septal myocard

Hypertrophic obstructive cardiomyopathy (HOCM)is a genetic disorder characterized by severe asymmetric hypertrophy of the interventricular septum (IVS) in the absence of any other systemic or cardiac diseases.